Varinos Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$7.89M
- Investors
-
14
Varinos General Information
Description
Developer of genome analysis technology designed to provide contract testing and analysis services for reproductive medicine, obstetrics, and gynecology. The company's technology has made it possible to detect microscopic amounts of bacteria, which examines and diagnoses the presence or absence of abnormalities by examining the genes and chromosomes of embryos before pregnancy is established, enabling women to reduce physical and mental burdens.
Contact Information
Website
www.varinos.comCorporate Office
- DiverCity Tokyo Office Tower
- 21st floor, 1-1-20 Aomi, Koto-ku
- Tokyo, 135-0064
- Japan
Corporate Office
- DiverCity Tokyo Office Tower
- 21st floor, 1-1-20 Aomi, Koto-ku
- Tokyo, 135-0064
- Japan
Varinos Timeline
Varinos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 12-May-2026 | $7.89M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 24-Nov-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series C) | 03-Aug-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 11-Sep-2020 | $2.83M | $4.63M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 29-Jan-2018 | $1.8M | $1.8M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Varinos Comparisons
Industry
Financing
Details
Varinos Competitors (7)
One of Varinos’s 7 competitors is BioFire, a Venture Capital-Backed company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioFire | Venture Capital-Backed | Salt Lake City, UT | ||||
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| Igenomix USA | Formerly PE-Backed | Paterna, Spain | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT |
Varinos Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Varinos Patents
Varinos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026139358-A | Monitoring of viral sequences in virus-infected tissues | Pending | 20-Feb-2025 | ||
| JP-2022136465-A | Mechanical detection of breakpoint candidate of copy number variant on genome sequence | Active | 08-Mar-2021 | ||
| WO-2022190495-A1 | Mechanical detection of breakpoint candidate of copy number variant on genome sequence | Inactive | 08-Mar-2021 | ||
| JP-7099759-B1 | Mechanical detection of candidate break points for variants in the number of copies on the genome sequence | Active | 08-Mar-2021 | ||
| JP-7124148-B1 | Metagenome analysis of microbiota | Active | 08-Mar-2021 | G16B40/00 |
Varinos Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Varinos Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mirai Souzou Investments | Venture Capital | Minority | ||
| Mirai Sozo Capital | Corporate Venture Capital | Minority | ||
| Mitsui Chemicals | Corporation | Minority | ||
| Yokohama Capital | Venture Capital | Minority | ||
| Mitsubishi UFJ Capital | Venture Capital | Minority |
Varinos Acquisitions (1)
Varinos’s most recent deal was a Merger/Acquisition with MySkin. The deal was made on 01-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MySkin | 01-Nov-2026 | Merger/Acquisition | Biotechnology |
Varinos Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| MySkin | Tokyo, Japan | 2014 |
Varinos FAQs
-
When was Varinos founded?
Varinos was founded in 2017.
-
Where is Varinos headquartered?
Varinos is headquartered in Tokyo, Japan.
-
What is the size of Varinos?
Varinos has 50 total employees.
-
What industry is Varinos in?
Varinos’s primary industry is Other Healthcare Technology Systems.
-
Is Varinos a private or public company?
Varinos is a Private company.
-
What is Varinos’s current revenue?
The current revenue for Varinos is .
-
How much funding has Varinos raised over time?
Varinos has raised $18.3M.
-
Who are Varinos’s investors?
Mirai Souzou Investments, Mirai Sozo Capital, Mitsui Chemicals, Yokohama Capital, and Mitsubishi UFJ Capital are 5 of 14 investors who have invested in Varinos.
-
Who are Varinos’s competitors?
BioFire, ARUP Laboratories, Cepheid, Igenomix USA, and Myriad Genetics are some of the 7 competitors of Varinos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
